Background: Advances in artificial intelligence (AI) technology have raised new possibilities for the effective evaluation of daily dietary intake, but more empirical study is needed for the use of such technologies under realistic meal…
Continue Reading
What You Should Know:
– Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer tests, announced today that the U.S. Food and Drug Administration (FDA) has granted De Novo authorization for ArteraAI…
Continue Reading
What You Should Know:
– The U.S. Food and Drug Administration (FDA) is requiring safety labeling changes to all opioid pain medications to better emphasize and explain the risks associated with their long-term use.
– The…
Continue Reading
🎤 This isn’t your typical conference…DirectTrust’s upcoming event is shaping up to be something special. In this quick video, John Lynn chats with Kathryn Ayers Wickenhauser, Chief Strategy Officer at DirectTrust, about how they’re…
Continue Reading
A £7.5 million global challenge prize has launched to incentivise AI-based approaches to transform drug discovery for the treatment of amyotrophic lateral sclerosis (ALS).
ALS is a form of motor neurone disease (MND) that damages the…
What You Should Know:
– NationsBenefits®, the leading supplemental benefits and healthcare fintech solutions provider is proud to announce a new partnership with Dollar General, the largest discount retailer in the United States by store count.
– By…
Continue Reading
What You Should Know:
– PathAI, a global leader in artificial intelligence (AI) and digital pathology solutions, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its digital…
Continue Reading
Leah Dewey, VP of Clinical and Consumer Engagement Operations, Cotiviti
According to the Centers for Disease Control and Prevention (CDC), rural Americans have a higher risk of premature death from heart disease, cancer, respiratory disease,…
Continue Reading
Image Credit: bipartisanpolicy
What You Should Know:
– A new report from the Bipartisan Policy Center (BPC) examines the complex and often fragmented regulatory landscape for health AI tools that fall outside the jurisdiction of the…
Continue Reading
Regulatory agencies, such as the European Commission and the U.S. Food and Drug Administration, are now permitting electronic instructions for use (eIFUs) to be distributed alongside paper instructions for use (IFUs) for medical devices….
Continue Reading
